Evidence map›Paper›PMID 31764981›Full record

ArticleTranslational behavioral medicine2021

A retrospective multisite examination of depression screening practices, scores, and correlates in pediatric diabetes care.

Shelagh A Mulvaney, Constance A Mara, Jessica C Kichler, Shideh Majidi, Kimberly A Driscoll, Sarah C Westen, Alana Rawlinson, Laura M Jacobsen, Rebecca N Adams, Korey K Hood and 1 more

Open access · greenAbstract read
In one paragraph

Article in Translational behavioral medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 1 country.

Shelagh A MulvaneyVanderbilt University, Nashville, TN, USA.
Constance A MaraCincinnati Children's Hospital, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
Jessica C KichlerCincinnati Children's Hospital, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
Shideh MajidiBarbara Davis Diabetes Center, Aurora, CO, USA.
Kimberly A DriscollBarbara Davis Diabetes Center, Aurora, CO, USA.
Sarah C WestenUniversity of Florida, Gainesville, FL, USA.
Alana RawlinsonUniversity of Florida, Gainesville, FL, USA.
Laura M JacobsenUniversity of Florida, Gainesville, FL, USA.
Rebecca N AdamsStanford University School of Medicine, Palo Alto, CA, USA.
Korey K HoodStanford University School of Medicine, Palo Alto, CA, USA.
Maureen MonaghanChildren's National Health System, Washington, DC, USA.
University of Florida · USCincinnati Children's Hospital Medical Center · USPalo Alto University · USSansum Diabetes Research Institute · USChildren's National · USVanderbilt University · US

Funding

Vanderbilt Institute for Clinical and Translational Research (VICTR) -Identifying correlates of functional immunity in SARS-CoV-2 convalescent plasmaUL1TR002243 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Paul A. Harris, Wesley H Self · 2017 to 2026
$130.7M
Using social networks to map and evaluate team science across CTSA hubsUL1TR001427 · NCATS · UNIVERSITY OF FLORIDA · PI MITCHELL, DUANE A. · 2015 to 2024
$37.2M
NCATS NIH HHS UL1 TR001427NCATS NIH HHS UL1 TR002243
6 · The paper itself

Abstract

Psychosocial guidelines recommend routine screening of depressive symptoms in adolescents and young adults (AYA) with diabetes. Best practices for screening in routine care and patient characteristics associated with depressive symptoms require further investigation. The purpose of this study was to examine psychometric properties of the Patient Health Questionnaire (PHQ-2 and PHQ-9); document rates of depressive symptoms and related clinical actions; and evaluate associations with patient characteristics. The Patient Health Questionnaire (PHQ-2 or PHQ-9) was administered at five pediatric academic medical centers with 2,138 youth with type 1 diabetes. Screening was part of routine clinical care; retrospective data from electronic health records were collected for the first screening date as well as 12 months prior. The PHQ demonstrated good psychometric properties. Evaluation of item-level PHQ-9 data identified 5.0% of AYA with at least moderate depressive symptoms who would not have been flagged for further screening using the PHQ-2 only. On the PHQ-9, 10.0% of AYA with type 1 diabetes endorsed elevated depressive symptoms and 7.0% endorsed thoughts of self-harm. Patients with moderate or greater depressive symptoms had a 43.9% documented referral rate for mental health treatment. Higher BMI, older age, public insurance, shorter diabetes duration, higher HbA1C, and a diabetic ketoacidosis (DKA) event in the past year were associated with depressive symptoms. The PHQ-9 identified AYA with elevated depressive symptoms that would not have been identified using the PHQ-2. Depressive symptoms were associated with negative diabetes indicators. To improve referral rates, standardized methods for provision and documentation of referrals are needed.

Indexed as

DepressionDiabetes Mellitus, Type 1AdolescentAgedChildHumansMass ScreeningPsychometricsRetrospective StudiesSurveys and QuestionnairesYoung AdultDepressionDiabetesPatient Health Questionnaire (PHQ)PediatricsScreening

Identifiers

PMID31764981
PMCPMC7877294
OpenAlexW2991137526

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.